Different regimens of perioperative chemotherapy for esophagogastric and gastric adenocarcinoma: does a triplet therapy with taxane generate a survival benefit?
- PMID: 28447060
- PMCID: PMC5388624
- DOI: 10.21037/tgh.2017.03.07
Different regimens of perioperative chemotherapy for esophagogastric and gastric adenocarcinoma: does a triplet therapy with taxane generate a survival benefit?
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Comment on
-
Influence of Different Neoadjuvant Chemotherapy Regimens on Response, Prognosis, and Complication Rate in Patients with Esophagogastric Adenocarcinoma.Ann Surg Oncol. 2015 Dec;22 Suppl 3:S905-14. doi: 10.1245/s10434-015-4617-x. Epub 2015 May 22. Ann Surg Oncol. 2015. PMID: 26001861
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources